← Back to Search

Exercise Treatment Group for Exercise (SCA Trial)

N/A
Waitlist Available
Led By Foluso J Ogunsile, MD
Research Sponsored by Memorial Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

SCA Trial Summary

This trial will test if exercise can improve the quality of life for adults with sickle cell anemia who also have cardiopulmonary disease.

Eligible Conditions
  • Exercise
  • Sickle Cell Disease
  • Cardiovascular Disease

SCA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Specific exercise regimen for those living with sickle cell disease

SCA Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise Treatment GroupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Memorial Healthcare SystemLead Sponsor
8 Previous Clinical Trials
1,170 Total Patients Enrolled
1 Trials studying Exercise
10 Patients Enrolled for Exercise
University of Alabama at BirminghamLead Sponsor
1,581 Previous Clinical Trials
2,277,914 Total Patients Enrolled
9 Trials studying Exercise
586 Patients Enrolled for Exercise
Foluso J Ogunsile, MDPrincipal InvestigatorMemorial Healthcare System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025